The Model for End-Stage Liver Disease score may have eliminated racial disparities on the waitlist for liver transplantation (LT), but disparities prior to waitlist placement have not been adequately quantified. We aimed to analyze differences in patients who are listed for LT, undergo transplantation, and die from end-stage liver disease (ESLD), stratified by state and race/ethnicity.

Approach and Results

We analyzed two databases retrospectively, the Center for Disease Control Wide-ranging Online Data for Epidemiologic Research (CDC WONDER) and the United Network for Organ Sharing (UNOS) databases, from 2014 to 2018. We included patients aged 25-64 years who had a primary cause of death of ESLD and were listed for transplant in the CDC WONDER or UNOS database. Our primary outcome was the ratio of listing for LT to death from ESLD—listing to death ratio (LDR). Our secondary outcome was the transplant to listing and transplant to death ratios. Chi-squared and multivariable linear regression evaluated for differences between races/ethnicities. There were 135,367 patients who died of ESLD, 54,734 patients who were listed for transplant, and 26,571 who underwent transplant. Patients were mostly male and White. The national LDR was 0.40, significantly lowest in Black patients (0.30), P < 0.001. The national transplant to listing ratio was 0.48, highest in Black patients (0.53), P < 0.01. The national transplant to death ratio was 0.20, lowest in Black patients (0.16), P < 0.001. States that had an above-mean LDR had a lower transplant to listing ratio but a higher transplant to death ratio. Multivariable analysis confirmed that Black race is significantly associated with a lower LDR and transplant to death ratio.

Conclusions

Black patients face a disparity in access to LT due to low listing rates for transplant relative to deaths from ESLD.

Supporting Information

References

1Murray CJL, Mokdad AH, Ballestros K, Echko M, Glenn S, Olsen HE, et al. The state of US health, 1990-2016: burden of diseases, injuries, and risk factors among US states. JAMA 2018; 319: 1444-1472.
10.1001/jama.2018.0158
PubMed Web of Science® Google Scholar
2Hirode G, Saab S, Wong RJ. Trends in the burden of chronic liver disease among hospitalized US adults. JAMA Netw Open 2020; 3:e201997.
10.1001/jamanetworkopen.2020.1997
PubMed Web of Science® Google Scholar
3Martin P, DiMartini A, Feng S, Brown R Jr, Fallon M. Evaluation for liver transplantation in adults: 2013 practice guideline by the American Association for the Study of Liver Diseases and the American Society of Transplantation. Hepatology 2014; 59: 1144-1165.
10.1002/hep.26972
CAS PubMed Web of Science® Google Scholar
4 United Network for Organ Sharing. Transplant trends. https://unos.org/data/transplant-trends/. Accessed January 4, 2021.
Google Scholar
5Allen AM, Heimbach JK, Larson JJ, Mara KC, Kim WR, Kamath PS, et al. Reduced access to liver transplantation in women: role of height, MELD exception scores, and renal function underestimation. Transplantation 2018; 102: 1710-1716.
10.1097/TP.0000000000002196
PubMed Web of Science® Google Scholar
6Verna EC, Lai JC. Time for action to address the persistent sex-based disparity in liver transplant access. JAMA Surg 2020; 155: 545-547.
10.1001/jamasurg.2020.1126
PubMed Web of Science® Google Scholar
7Mathur AK, Schaubel DE, Gong Q, Guidinger MK, Merion RM. Racial and ethnic disparities in access to liver transplantation. Liver Transpl 2010; 16: 1033-1040.
10.1002/lt.22108
PubMed Web of Science® Google Scholar
8Tapper EB, Parikh ND. Mortality due to cirrhosis and liver cancer in the United States, 1999-2016: observational study. BMJ 2018; 362:k2817.
10.1136/bmj.k2817
PubMed Google Scholar
9Reid AE, Resnick M, Chang YC, Buerstatte N, Weissman JS. Disparity in use of orthotopic liver transplantation among Blacks and Whites. Liver Transpl 2004; 10: 834-841.
10.1002/lt.20174
PubMed Web of Science® Google Scholar
10Eckhoff DE, McGuire BM, Young CJ, Sellers MT, Frenette LR, Hudson SL, et al. Race: a critical factor in organ donation, patient referral and selection, and orthotopic liver transplantation? Liver Transpl Surg 1998; 4: 499-505.
10.1002/lt.500040606
CAS PubMed Web of Science® Google Scholar
11Nguyen GC, Segev DL, Thuluvath PJ. Racial disparities in the management of hospitalized patients with cirrhosis and complications of portal hypertension: a national study. Hepatology 2007; 45: 1282-1289.
10.1002/hep.21580
PubMed Web of Science® Google Scholar
12Jesse MT, Abouljoud M, Goldstein ED, Rebhan N, Ho C-X, Macaulay T, et al. Racial disparities in patient selection for liver transplantation: an ongoing challenge. Clin Transplant 2019; 33:e13714.
10.1111/ctr.13714
PubMed Web of Science® Google Scholar
13Moylan CA, Brady CW, Johnson JL, Smith AD, Tuttle-Newhall JE, Muir AJ. Disparities in liver transplantation before and after introduction of the MELD score. JAMA 2008; 300: 2371-2378.
10.1001/jama.2008.720
Web of Science® Google Scholar
14Julapalli VR, Kramer JR, El-Serag HB. Evaluation for liver transplantation: adherence to AASLD referral guidelines in a large Veterans Affairs center. Liver Transpl 2005; 11: 1370-1378.
10.1002/lt.20434
PubMed Web of Science® Google Scholar
15Bryce CL, Angus DC, Arnold RM, Chang CCH, Farrell MH, Manzarbeitia C, et al. Sociodemographic differences in early access to liver transplantation services. Am J Transplant 2009; 9: 2092-2101.
10.1111/j.1600-6143.2009.02737.x
CAS PubMed Web of Science® Google Scholar
16Wilder JM, Oloruntoba OO, Muir AJ, Moylan CA. Role of patient factors, preferences, and distrust in health care and access to liver transplantation and organ donation. Liver Transpl 2016; 22: 895-905.
10.1002/lt.24452
PubMed Web of Science® Google Scholar
17Mathur AK, Ashby VB, Fuller DS, Zhang M, Merion RM, Leichtman A, et al. Variation in access to the liver transplant waiting list in the United States. Transplantation 2014; 98: 94-99.
10.1097/01.TP.0000443223.89831.85
PubMed Web of Science® Google Scholar
18Tapper EB, Korovaichuk S, Baki J, Williams S, Nikirk S, Waljee AK, et al. Identifying patients with hepatic encephalopathy using administrative data in the ICD-10 era. Clin Gastroenterol Hepatol 2021; 19: 604-606.
10.1016/j.cgh.2019.12.017
PubMed Web of Science® Google Scholar
19Ramrakhiani N, Le M, Yeo YH, Le A, Maeda M, Nguyen M. Validity of International Classification of Diseases, 10th revision, codes for cirrhosis. Dig Dis Sci 2020 Aug 19. https://doi.org/10.1159/000510981. [Epub ahead of print]
Google Scholar
20 US Department of Health and Human Services. Organ Procurement and Transplantation Network. State data. https://optn.transplant.hrsa.gov/data/view-data-reports/state-data/. Accessed January 4, 2021.
Google Scholar
21Ross K, Patzer RE, Goldberg DS, Lynch RJ. Sociodemographic determinants of waitlist and posttransplant survival among end-stage liver disease patients. Am J Transplant 2017; 17: 2879-2889.
10.1111/ajt.14421
CAS PubMed Web of Science® Google Scholar
22Yu JC, Neugut AI, Wang S, Jacobson JS, Ferrante L, Khungar V, et al. Racial and insurance disparities in the receipt of transplant among patients with hepatocellular carcinoma. Cancer 2010; 116: 1801-1809.
10.1002/cncr.24936
PubMed Web of Science® Google Scholar
23Kirby JB, Kaneda T. Unhealthy and uninsured: exploring racial differences in health and health insurance coverage using a life table approach. Demography 2010; 47: 1035-1051.
10.1007/BF03213738
PubMed Web of Science® Google Scholar
24. Health coverage by race and ethnicity: the potential impact of the Affordable Care Act. https://www.kff.org/disparities-policy/issue-brief/health-coverage-by-race-and-ethnicity-the-potential-impact-of-the-affordable-care-act/. Accessed June 11, 2020.
Google Scholar
25Kemmer N, Zacharias V, Kaiser TE, Neff GW. Access to liver transplantation in the MELD era: role of ethnicity and insurance. Dig Dis Sci 2009; 54: 1794-1797.
10.1007/s10620-008-0567-5
PubMed Web of Science® Google Scholar
26Wong RJ, Devaki P, Nguyen L, Cheung R, Nguyen MH. Ethnic disparities and liver transplantation rates in hepatocellular carcinoma patients in the recent era: results from the Surveillance, Epidemiology, and End Results registry. Liver Transpl 2014; 20: 528-535.
10.1002/lt.23820
PubMed Web of Science® Google Scholar
27Dakhoul L, Gawrieh S, Jones K, Ghabril M, McShane C, Orman E, et al. Racial disparities in liver transplantation for hepatocellular carcinoma are not explained by differences in comorbidities, liver disease severity, or tumor burden. Hepatol Commun 2018; 3: 52-62.
10.1002/hep4.1277
PubMed Web of Science® Google Scholar
28Walker RJ, Strom Williams J, Egede LE. Influence of race, ethnicity and social determinants of health on diabetes outcomes. Am J Med Sci 2016; 351: 366-373.
10.1016/j.amjms.2016.01.008
PubMed Web of Science® Google Scholar
29White DL, Thrift AP, Kanwal F, Davila J, El-Serag HB. Incidence of hepatocellular carcinoma in all 50 United States, from 2000 through 2012. Gastroenterology 2017; 152: 812-820.e5.
10.1053/j.gastro.2016.11.020
PubMed Web of Science® Google Scholar
30Saab S, Manne V, Nieto J, Schwimmer JB, Chalasani NP. Nonalcoholic fatty liver disease in Latinos. Clin Gastroenterol Hepatol 2016; 14: 5-12.
10.1016/j.cgh.2015.05.001
PubMed Web of Science® Google Scholar
31Ha J, Yan M, Aguilar M, Tana M, Liu B, Frenette CT, et al. Race/ethnicity-specific disparities in hepatocellular carcinoma stage at diagnosis and its impact on receipt of curative therapies. J Clin Gastroenterol 2016; 50: 423-430.
10.1097/MCG.0000000000000448
PubMed Web of Science® Google Scholar
32 Organ Procurement and Transplantation Network. Median MELD at transplant by donor service area and median PELD at transplant within the nation. https://optn.transplant.hrsa.gov/media/3180/mts_dsa_distribution_20190924.pdf. Published September 18, 2019. Accessed July 8, 2020.
Google Scholar
33Goldberg DS, French B, Forde KA, Groeneveld PW, Bittermann T, Backus L, et al. Association of distance from a transplant center with access to waitlist placement, receipt of liver transplantation, and survival among US veterans. JAMA 2014; 311: 1234-1243.
10.1001/jama.2014.2520
CAS PubMed Web of Science® Google Scholar
34Axelrod DA, Guidinger MK, Finlayson S, Schaubel DE, Goodman DC, Chobanian M, et al. Rates of solid-organ wait-listing, transplantation, and survival among residents of rural and urban areas. JAMA 2008; 299: 202-207.
10.1001/jama.2007.50
CAS PubMed Web of Science® Google Scholar
35Cullaro G, Sarkar M, Lai JC. Sex-based disparities in delisting for being “too sick” for liver transplantation. Am J Transplant 2018; 18: 1214-1219.
10.1111/ajt.14608
CAS PubMed Web of Science® Google Scholar

Citing Literature

Volume74, Issue3

September 2021

Pages 1523-1532

This article also appears in:

Celebrating Black History Month

Black Patients Have Unequal Access to Listing for Liver Transplantation in the United States

Abstract

Background and Aims

Approach and Results

Conclusions

Supporting Information

References

Citing Literature

References

Information

About Wiley Online Library

Help & Support

Opportunities

Connect with Wiley

Black Patients Have Unequal Access to Listing for Liver Transplantation in the United States

Abstract

Background and Aims

Approach and Results

Conclusions

Supporting Information

References

Citing Literature

References

Related

Information